Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Abelcet prophylaxis for invasive pulmonary aspergillosis in children with acute leukemia
2011-000499-32Phase 2Active
- Sponsor
- Fundació Sant Joan de Déu
- Start
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of amphotericin b in Acute Invasive Aspergillosis, sponsored by Fundació Sant Joan de Déu. Primary endpoint: Treatment discontinuation due to adverse events or intolerability. Started Jun 2011; status: active.
02
Drugs
amphotericin b
03
Conditions
Acute Invasive Aspergillosis
Beyond the preview
Go deeper on 2011-000499-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000499-32.